What is DiA Imaging Analysis?
Founded in 2009 and headquartered in Israel, DiA Imaging Analysis specializes in the development of AI-based software designed to automate the analysis of ultrasound images. The company's core value proposition lies in its ability to make ultrasound technology more accessible and accurate for clinicians, regardless of their level of expertise. By integrating automated, real-time analysis directly into the imaging process, DiA reduces the subjectivity inherent in manual interpretation, thereby enhancing diagnostic precision and operational efficiency in healthcare settings.
The company operates at the intersection of deep tech and clinical medicine, positioning itself as an essential partner for healthcare providers seeking to optimize patient outcomes through digital transformation. Its platform is engineered to integrate seamlessly with existing ultrasound hardware, ensuring that its advanced analytical capabilities are readily available to medical professionals across diverse clinical environments.
How much funding has DiA Imaging Analysis raised?
DiA Imaging Analysis has raised a total of $19M across 2 funding rounds:
Unspecified
$5M
Series B
$14M
Unspecified (2018): $5M with participation from Connecticut Innovations, DEFTA Partners, and Israel Innovation Authority
Series B (2021): $14M led by Connecticut Innovations, XTX Ventures, Downing Ventures, DEFTA Partners, Dr Shmuel Cabilly, Philips, Mindset Ventures, CE Ventures, Icon Advisers, and Alchimia Ventures
Key Investors in DiA Imaging Analysis
DEFTA Partners
A global venture investment firm focusing on transformative technologies in healthcare and information communication technology, with a strong presence in North America, Asia, and the Middle East.
Connecticut Innovations
The strategic venture capital arm of Connecticut, providing equity financing and guidance to help innovative companies in sectors like biosciences and AI scale effectively.
Israel Innovation Authority
A government-backed entity dedicated to driving technological innovation in Israel by supporting entrepreneurs and startups through tailored funding programs and R&D initiatives.
What's next for DiA Imaging Analysis?
With the recent influx of capital, DiA Imaging Analysis is well-positioned to accelerate its international expansion and deepen its product development pipeline. The company is expected to focus on scaling its enterprise-level deployments, ensuring that its AI-powered solutions become a standard component of modern diagnostic suites. Strategic priorities likely include the expansion of its regulatory footprint and the enhancement of its software to support a broader range of clinical applications, including point-of-care ultrasound (POCUS) and remote diagnostic capabilities.
As the healthcare industry continues to prioritize efficiency and data-driven decision-making, DiA's focus on automating the interpretation of complex medical imagery will remain a critical growth driver. The company's ability to maintain its technological edge while navigating the complexities of global healthcare markets will be the primary determinant of its long-term success in the competitive landscape of medical AI.
